# Anticoagulants Comparative Benefit-risk Ratio in Real Life

> **NCT02785354** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 103101 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02785354
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-01
- **Primary completion:** 2016-03-04
- **Final completion:** 2016-04-05
- **Target enrollment:** 103101 (ACTUAL)
- **Last updated:** 2018-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02785354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02785354, "Anticoagulants Comparative Benefit-risk Ratio in Real Life". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02785354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*